HomeInsightsMarket Capitalization

Market Capitalization of Procter & Gamble Health Ltd

Market Capitalization of Procter & Gamble Health Ltd

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

1.1 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Procter & Gamble Health Ltd

NSE: PGHL

MARKETCAP

₹ 9435.19 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Procter & Gamble Health Ltd is ₹ 9435 crore as of 07 Nov 24.
  • The Market Cap of Procter & Gamble Health Ltd changed from ₹ 6751 crore to ₹ 8713 crore over 4 quarters. This represents a CAGR of 29.06% .
  • The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5683 as of 07 Nov 15:30.
  • The Dividend Payouts of Procter & Gamble Health Ltd changed from ₹ 11.5 on Nov 15, 2022 to ₹ 60 on Nov 28, 2024 . This represents a CAGR of 31.70% over 6 years. .

Historical Market Cap of Procter & Gamble Health Ltd

No data available

* All values are in crore

Company Fundamentals for Procter & Gamble Health Ltd

No data available

Image

Procter & Gamble Health Ltd

NSE: PGHL

PRICE

₹ 5683.85

-91.10 (-1.58%)

stock direction

Last updated on: Nov 07 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20245683.85
06 Nov 20245774.95
05 Nov 20245537.2
04 Nov 20245279.05
01 Nov 20245196.4
31 Oct 20245234.25
30 Oct 20245064.9
29 Oct 20244998.9
28 Oct 20244997.9
25 Oct 20244990.25

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Procter & Gamble Health Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Procter & Gamble Health Ltd

No data available

No data available

Historical P/E Ratio of Procter & Gamble Health Ltd

No data available

* All values are in %

Historical Revenue of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical EBITDA of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Net Profit of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Procter & Gamble Health Ltd

No data available

* All values are in

About Procter & Gamble Health Ltd

  • Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
  • The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products.
  • They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs. The company operates in two business divisions, namely Pharmaceuticals and Chemicals.
  • The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products.

Procter & Gamble Health Ltd News Hub

News

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore ...

Read more

05 Nov 202409:59

News

Procter & Gamble Health to hold board meeting

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 4 ...

Read more

28 Sep 202410:06

News

Procter & Gamble Health schedules AGM

Procter & Gamble Health announced that the 57th Annual General Meeting (AGM) of the compan...

Read more

23 Aug 202411:48

News

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, ...

Read more

22 Aug 202410:02

News

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

21 Aug 202417:54

News

Procter & Gamble Health announces board meeting date

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 21...

Read more

28 Jun 202411:17

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Procter & Gamble Health Ltd Market Cap

What is the market cap of Procter & Gamble Health Ltd?

As of November 8, 2024, Procter & Gamble Health Ltd has a market capitalization of ₹9435.19, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Procter & Gamble Health Ltd's market capitalization?

Procter & Gamble Health Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Procter & Gamble Health Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Procter & Gamble Health Ltd's market capitalization change?

Procter & Gamble Health Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*